IMM60 and Pembrolizumab Study for Advanced Melanoma & NSCLC

Name: IMM60 and Pembrolizumab Study for Advanced Melanoma & NSCLC
Uploaded: 2023-06-10T04:52:35
Duration: 12 min 4 s
Description: Ian B. Walters, MD - Portage Biotech Inc The IMPORT-201 study investigates the use of IMM60, a novel iNKT agonist, in combination with pembrolizumab for advanced melanoma and metastatic non-small cell lung cancer (NSCLC). Preclinical studies have shown promising results, including tumor regression and immune activat...

Phase 1/2 study (IMPORT-201) demonstrates the safety and efficacy of IMM60, a novel iNKT agonist, as monotherapy and in combination with pembrolizumab for advanced melanoma and metastatic non-small cell lung cancer, showing potential for immune activation in heavily pre-treated patients.

0:12:04

Oncology Conferences

3 months 185 Views

Share Add to Report 0 0

Embed (Iframe):

<div class="embed-responsive embed-responsive-16by9"><iframe width="640" height="360" style="max-width: 100%;max-height: 100%; border:none;" src="https://oncologytube.com/videoEmbed/42076/imm60?channelName=OncologyConferences&modestbranding=1&showinfo=1&autoplay=&controls=1&loop=&mute=&t=0&objectFit=" frameborder="0" allowfullscreen="allowfullscreen" allow="autoplay" scrolling="no">iFrame is not supported!</iframe></div>

Embed (Object):

<div class="embed-responsive embed-responsive-16by9"><object width="640" height="360"><param name="movie" value="https://oncologytube.com/videoEmbed/42076/imm60?channelName=OncologyConferences&modestbranding=1&showinfo=1&autoplay=&controls=1&loop=&mute=&t=0&objectFit="></param><param name="allowFullScreen" value="true"></param><param name="allowscriptaccess" value="always"></param><embed src="https://oncologytube.com/videoEmbed/42076/imm60?channelName=OncologyConferences&modestbranding=1&showinfo=1&autoplay=&controls=1&loop=&mute=&t=0&objectFit=" allowscriptaccess="always" allowfullscreen="true" width="640" height="360"></embed></object></div>

Link (HTML):

<a href="https://oncologytube.com/v/42076?channelName=OncologyConferences"><img src="https://oncologytubecom.cdn.ypt.me/videos/video_230610115235_v8888/video_230610115235_v8888.jpg?cache=16864161261691418908">IMM60 and Pembrolizumab Study for Advanced Melanoma & NSCLC</a>

Link (BBCode):

[url=https://oncologytube.com/v/42076?channelName=OncologyConferences][img]https://oncologytubecom.cdn.ypt.me/videos/video_230610115235_v8888/video_230610115235_v8888.jpg?cache=16864161261691418908[/img]IMM60 and Pembrolizumab Study for Advanced Melanoma & NSCLC[/url]

Sign in now!

Permanent Link

URL Friendly (SEO)

Current Time (SEO)

Category:

Non-Small Cell Lung Cancer

Description:

Ian B. Walters, MD - Portage Biotech Inc

The IMPORT-201 study investigates the use of IMM60, a novel iNKT agonist, in combination with pembrolizumab for advanced melanoma and metastatic non-small cell lung cancer (NSCLC). Preclinical studies have shown promising results, including tumor regression and immune activation. Initial results from the phase 1 portion of the study demonstrate that IMM60, as monotherapy and in combination with pembrolizumab, is well-tolerated and shows potential in inducing positive treatment responses, warranting further investigation in heavily pretreated patients.